Corvese Brian

CIK 00013932073 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001393207

Recent Transactions

50 trades

Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2026-09-01$10.95/sh+1,633→ 54,770 total
Award
AGENUS INC$AGEN
Stock Option
2026-08-05+100,000→ 100,000 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2026-06-01$12.38/sh+1,444→ 53,137 total
Award
AGENUS INC$AGEN
Stock Option
2026-04-24+210,000→ 210,000 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2026-03-02$10.90/sh+1,640→ 51,693 total
Award
MiNK Therapeutics, Inc.$INKT
Stock Option (Right to Buy)
2026-01-02+5,395→ 5,395 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2025-12-01$11.09/sh+1,612→ 50,053 total
Award
MiNK Therapeutics, Inc.$INKT
Stock Option (Right to Buy)
2025-09-09+3,225→ 3,225 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2025-09-02$13.86/sh+1,290→ 48,441 total
Award
AGENUS INC$AGEN
Stock Option
2025-06-17+750→ 750 total
Award
AGENUS INC$AGEN
Stock Option
2025-06-17+30,000→ 30,000 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2025-06-02$7.17/sh+2,494→ 47,151 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2025-03-03$8.79/sh+2,033→ 44,657 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2024-12-01$0.73/sh+24,400→ 426,283 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2024-09-03$0.82/sh+21,802→ 405,296 total
Award
AGENUS INC$AGEN
Stock Option
2024-06-11+750→ 750 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2024-06-03$0.99/sh+17,967→ 383,494 total
Award
Protagenic Therapeutics, Inc.\new$PTIX
PTIX Common stock Options
2024-03-25$1.74/sh+43,750→ 43,750 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2024-03-01$0.95/sh+18,816→ 365,527 total
Award
AGENUS INC$AGEN
Stock Option
2024-02-05+15,000→ 15,000 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2023-12-01$1.04/sh+17,188→ 346,711 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2023-09-01$1.46/sh+12,244→ 329,523 total
Award
MiNK Therapeutics, Inc.$INKT
Stock Option (Right to Buy)
2023-06-14+37,500→ 37,500 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2023-06-01$1.76/sh+10,157→ 317,505 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2023-03-01$2.09/sh+8,553→ 307,348 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2022-12-01$2.61/sh+6,849→ 298,795 total
Award
MiNK Therapeutics, Inc.$INKT
Common Stock
2022-09-15$2.62/sh+13,646→ 13,646 total
Award
MiNK Therapeutics, Inc.$INKT
Stock Option (Right to Buy)
2022-03-09+25,000→ 25,000 total
Award
AGENUS INC$AGEN
Stock Option (Right to Buy)
2022-02-04+150,000→ 150,000 total
Exercise/Conversion
AGENUS INC$AGEN
Common Stock
2021-06-16+22,471→ 92,085 total
Exercise/Conversion
AGENUS INC$AGEN
Restricted Stock Unit
2021-06-16−16,000→ 16,000 total
Award
AGENUS INC$AGEN
Stock Option
2021-06-15+100,000→ 100,000 total
Award
AGENUS INC$AGEN
Stock Option (Right to buy)
2020-12-17+100,000→ 100,000 total
Exercise/Conversion
AGENUS INC$AGEN
Common Stock
2020-06-19+21,118→ 69,614 total
Exercise/Conversion
AGENUS INC$AGEN
Restricted Stock Unit
2020-06-19+21,118→ 0 total
Award
AGENUS INC$AGEN
Restricted Stock Unit
2020-06-16+22,471→ 49,589 total
Award
AGENUS INC$AGEN
Stock Option (Right to buy)
2020-06-16+2,500→ 2,500 total
Award
Protagenic Therapeutics, Inc.\new$PTIX
PTIX Common stock Options
2020-02-21+120,000→ 120,000 total
Award
AGENUS INC$AGEN
Stock Option (Right to buy)
2019-12-24+75,000→ 75,000 total
Award
AGENUS INC$AGEN
Restricted Stock Unit
2019-06-19+27,118→ 27,118 total
Award
AGENUS INC$AGEN
Stock Option, Right to buy
2019-06-19+100,000→ 102,500 total
Award
AGENUS INC$AGEN
Stock Option, Right to buy
2019-06-19+2,500→ 2,500 total
Award
AGENUS INC$AGEN
Stock Option, right to buy
2018-06-20$5.65/sh+37,500→ 37,500 total
Award
AGENUS INC$AGEN
Restricted Stock Unit
2018-06-20+21,276→ 21,276 total
Exercise/Conversion
AGENUS INC$AGEN
Restricted Stock Units
2018-03-31−21,220→ 0 total
Exercise/Conversion
AGENUS INC$AGEN
Common Stock
2018-03-31+21,220→ 21,220 total
Award
Protagenic Therapeutics, Inc.\new$PTIX
Non-Qualified Stock Options (Right to Buy)
2017-10-16+95,000→ 95,000 total
Award
AGENUS INC$AGEN
Stock Option, Right to buy
2017-06-29$3.91/sh+50,000→ 50,000 total
Award
AGENUS INC$AGEN
Stock Option, Right to buy
2017-06-29$3.91/sh+2,500→ 2,500 total
Award
AGENUS INC$AGEN
Restricted Stock Unit
2017-03-31+21,220→ 21,220 total

Corvese Brian

Recent Transactions

Companies

Recent Filings

Address